Ascendis Pharma A/SNASDAQ:ASND
No Matches were found for
- LAST PRICE135.6100
- TODAY'S CHANGE (%)-10.2800 (-7.0464%)
- Bid / Lots125.0000/ 1
- Ask / Lots169.5000/ 3
- Open / Previous Close145.0600 / 145.8900
- Day Range
- 52 Week Range
- Volume402,074
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ASND |
|---|---|---|
| 09:32 ET | 2045 | 145.06 |
| 09:33 ET | 200 | 145.075 |
| 09:35 ET | 100 | 145.69 |
| 09:39 ET | 100 | 143.2501 |
| 09:46 ET | 700 | 142.4 |
| 09:50 ET | 400 | 141.47 |
| 09:55 ET | 800 | 137.49 |
| 09:57 ET | 800 | 139.33 |
| 10:00 ET | 300 | 139.75 |
| 10:02 ET | 3536 | 139.895 |
| 10:04 ET | 800 | 140.06 |
| 10:06 ET | 1300 | 139.94 |
| 10:08 ET | 600 | 139.9 |
| 10:09 ET | 651 | 140.65 |
| 10:11 ET | 900 | 139.94 |
| 10:13 ET | 422 | 140.28 |
| 10:15 ET | 600 | 140.26 |
| 10:18 ET | 13940 | 140 |
| 10:20 ET | 873 | 139.28 |
| 10:24 ET | 700 | 139.17 |
| 10:27 ET | 214 | 138.49 |
| 10:29 ET | 100 | 139.23 |
| 10:31 ET | 1051 | 137.65 |
| 10:33 ET | 2381 | 137.69 |
| 10:36 ET | 2800 | 137.9996 |
| 10:38 ET | 606 | 137.73 |
| 10:42 ET | 300 | 137.73 |
| 10:45 ET | 3008 | 137.5 |
| 10:47 ET | 800 | 137.71 |
| 10:51 ET | 300 | 137.96 |
| 10:54 ET | 600 | 138.525 |
| 10:56 ET | 400 | 138.47 |
| 11:00 ET | 7082 | 140 |
| 11:02 ET | 8993 | 140 |
| 11:03 ET | 200 | 140.3 |
| 11:05 ET | 100 | 140.16 |
| 11:07 ET | 1381 | 140.2 |
| 11:09 ET | 300 | 140.5 |
| 11:14 ET | 100 | 140.61 |
| 11:16 ET | 398 | 140.57 |
| 11:18 ET | 1660 | 139.82 |
| 11:20 ET | 4676 | 139.85 |
| 11:21 ET | 600 | 139.8 |
| 11:23 ET | 565 | 139.67 |
| 11:30 ET | 200 | 140.09 |
| 11:36 ET | 1191 | 140.515 |
| 11:38 ET | 100 | 140.26 |
| 11:41 ET | 506 | 139.94 |
| 11:43 ET | 200 | 139.22 |
| 11:50 ET | 1233 | 140.38 |
| 11:59 ET | 235 | 138.9102 |
| 12:01 ET | 1780 | 138.005 |
| 12:03 ET | 400 | 138.27 |
| 12:06 ET | 200 | 138.29 |
| 12:10 ET | 3865 | 137.7 |
| 12:12 ET | 100 | 137.965 |
| 12:15 ET | 500 | 138.18 |
| 12:17 ET | 737 | 137.87 |
| 12:19 ET | 700 | 137.49 |
| 12:21 ET | 600 | 137.72 |
| 12:24 ET | 7067 | 137.03 |
| 12:26 ET | 600 | 137 |
| 12:28 ET | 200 | 136.41 |
| 12:32 ET | 2200 | 136.545 |
| 12:33 ET | 1400 | 136.79 |
| 12:35 ET | 5100 | 137.08 |
| 12:37 ET | 700 | 137.5 |
| 12:39 ET | 747 | 137.19 |
| 12:44 ET | 1000 | 137.74 |
| 12:46 ET | 200 | 138.14 |
| 12:48 ET | 500 | 137.44 |
| 12:50 ET | 100 | 137.31 |
| 12:53 ET | 100 | 137.465 |
| 01:00 ET | 300 | 138.47 |
| 01:02 ET | 500 | 137.745 |
| 01:06 ET | 100 | 137.955 |
| 01:13 ET | 100 | 138.69 |
| 01:15 ET | 100 | 138.715 |
| 01:18 ET | 200 | 138.55 |
| 01:20 ET | 1700 | 138.96 |
| 01:24 ET | 200 | 139.48 |
| 01:27 ET | 680 | 139.475 |
| 01:29 ET | 400 | 139.48 |
| 01:31 ET | 1108 | 139.2 |
| 01:33 ET | 100 | 139.02 |
| 01:36 ET | 227 | 139.005 |
| 01:40 ET | 500 | 138.45 |
| 01:42 ET | 100 | 138.565 |
| 01:45 ET | 450 | 138.4 |
| 01:47 ET | 900 | 138.4125 |
| 01:54 ET | 300 | 138.54 |
| 01:56 ET | 562 | 138.61 |
| 01:58 ET | 300 | 138.82 |
| 02:00 ET | 221 | 139.07 |
| 02:07 ET | 587 | 139 |
| 02:09 ET | 2250 | 138.725 |
| 02:12 ET | 1379 | 138.895 |
| 02:14 ET | 600 | 138.98 |
| 02:18 ET | 369 | 139.07 |
| 02:20 ET | 600 | 138.835 |
| 02:25 ET | 300 | 139.02 |
| 02:27 ET | 5200 | 139.04 |
| 02:32 ET | 1412 | 138.58 |
| 02:34 ET | 1400 | 138.505 |
| 02:36 ET | 400 | 138.53 |
| 02:43 ET | 300 | 138.75 |
| 02:50 ET | 424 | 138.38 |
| 02:56 ET | 300 | 138 |
| 02:59 ET | 800 | 137.855 |
| 03:01 ET | 1100 | 137.745 |
| 03:03 ET | 800 | 137.5975 |
| 03:06 ET | 2832 | 137.785 |
| 03:08 ET | 8428 | 137.955 |
| 03:10 ET | 9160 | 137.825 |
| 03:12 ET | 10883 | 138 |
| 03:14 ET | 3481 | 137.64 |
| 03:15 ET | 2883 | 136.775 |
| 03:17 ET | 600 | 136.29 |
| 03:19 ET | 1200 | 135.18 |
| 03:21 ET | 2200 | 135.15 |
| 03:24 ET | 2228 | 135.71 |
| 03:26 ET | 1655 | 135.76 |
| 03:28 ET | 3754 | 135.875 |
| 03:30 ET | 5110 | 136.0015 |
| 03:32 ET | 2200 | 136.75 |
| 03:33 ET | 1538 | 135.625 |
| 03:35 ET | 4500 | 136.005 |
| 03:37 ET | 10108 | 134.75 |
| 03:39 ET | 3040 | 134.01 |
| 03:42 ET | 3165 | 134.065 |
| 03:44 ET | 7192 | 134.185 |
| 03:46 ET | 2770 | 133.42 |
| 03:48 ET | 4946 | 133.97 |
| 03:50 ET | 12631 | 134.15 |
| 03:51 ET | 5966 | 134.285 |
| 03:53 ET | 5146 | 134.65 |
| 03:55 ET | 6107 | 135.34 |
| 03:57 ET | 11062 | 135.275 |
| 04:00 ET | 21259 | 135.61 |
Yesterday
Nov 18, 2021
BRIEF-Ascendis Pharma Announces Top-Line Results From Week 84 Of Its Phase 2 Path Forward Trial
6:17PM ET on Thursday Nov 18, 2021 by Thomson Reuters
Nov 16, 2021
Nov 15, 2021
--SVB Leerink Adjusts Ascendis Pharma's Price Target to $190 from $182, Keeps Outperform Rating
10:12AM ET on Monday Nov 15, 2021 by MT Newswires
Nov 12, 2021
Ascendis Pharma Says EMA Panel Issues Positive Opinion Backing Approval of Growth Hormone Deficiency Drug
9:57AM ET on Friday Nov 12, 2021 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ascendis Pharma A/S | 7.7B | -15.5x | --- |
Theralink Technologies Inc | 8.3B | 0.1x | --- |
CureVac NV | 8.1B | 0.0x | --- |
Mirati Therapeutics Inc | 7.3B | -13.9x | --- |
Intellia Therapeutics Inc | 7.5B | -30.1x | --- |
Biohaven Pharmaceutical Holding Company Ltd | 6.8B | -7.5x | --- |
Company Information
ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.
Contact Information
- Headquarters
- Tuborg Boulevard 12HELLERUP, Denmark 2900
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Senior Vice President, Chief Legal Officer
- Michael Jensen
- President, Chief Executive Officer, Board Member, Executive Director
- Jan Moller Mikkelsen
- Chief Financial Officer, Senior Vice President
- Scott Smith
- Senior Vice President, Chief Administrative Officer
- Lotte Soenderbjerg
- Senior Vice President of Clinical Development and Medical Affairs for Endocrine Medical Sciences
- Mark Bach
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.7B |
|---|---|
Revenue (TTM) | $3.9M |
Shares Outstanding | 56.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.74 |
EPS | $-8.75 |
Book Value | $17.65 |
P/E Ratio | -15.5x |
Price/Sales (TTM) | 1,995.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,729.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
